America's pharmaceutical future
America's pharmaceutical future is strengthened in Norwich, New York. For over 130 years, Norwich has been a bedrock of American pharmaceutical manufacturing. Today, Alvogen continues this proud tradition by producing high-quality generic medications that make healthcare more affordable and accessible for millions of Americans.
Who we are
Alvogen is a privately owned US-based company focused on developing, in-licensing, manufacturing and marketing pharmaceutical products.
Alvogen's companies include:
Alvogen generic business
Almatica brand products
Almaject injectables
Norwich US-based manufacturing
Targeted portfolio
Alvogen is growing its portfolio of complex, high value products including complex inhalation, injectables and strategic 505(b)(2) products.
Alvogen has over 50 products currently on market and extensive R&D capabilities fueling its growing pipeline.
Making a difference
Our true purpose as a company is to make people's lives better by producing high quality medicines that help people live longer, healthier and more active lives and making them more accessible to those who might not otherwise be able to afford them.
Open for collaboration
At Alvogen, we value partnerships and collaboration. Our future strategy relies heavily on our strategic selection of people and successful partnerships around the world.
